60 and older, any sex, with Advance Care Planning or Palliative Care. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants That Completed Patient Quality of Life SurveyPrimary· Collected upon admission to the nursing home (Baseline) and again 21 days post-admission to the nursing home (Follow up)
12-item survey that measures quality of life in five dimensions: 1) physical; 2) emotional; 3) psychological; 4) spiritual needs, and 5) provision of information and support. Items scored on a 5 point Likert Scale (0=not at all, 4= overwhelmingly) based on symptom/need in the past week. Overall profile score is calculated by summing responses (range 0-40). Source: patient or family caregiver; Time to complete: 5-7 minutes
Baseline
Group
Value
95% CI
Standard Care
4
Palliative Care Consult
3
Follow up
Group
Value
95% CI
Standard Care
3
Palliative Care Consult
3
Number of Participants That Completed Satisfaction With Care Survey (SWC-EOLD)Secondary· Collected upon admission to the nursing home and again 21 days post-admission to the nursing home
10-item scale that measures caregiver satisfaction with care for persons with dementia. Each item is measured on a 4-point Likert scale ranging from 1 ("strongly disagree") to 4 ("strongly agree"). Specific elements include satisfaction with medical and nursing care, decision-making, and their understanding of the persons with dementia illness. All items are summed, yielding a range of scores of 10-40. Higher scores indicate greater satisfaction.
Baseline SWC-EOLD
Group
Value
95% CI
Standard Care
4
Palliative Care Consult
3
Follow-up SWC-EOLD
Group
Value
95% CI
Standard Care
3
Palliative Care Consult
3
Number of Participants That Completed the Symptom Management Survey (SM-EOLD)Secondary· Collected upon admission to the nursing home and again 21 days post-admission to the nursing home
9-item scale administered to a caregiver that measures persons with dementia physical and psychological symptoms. Each item is rated on a 6-point Likert scale ranging from 0 to 5 (0 = "daily", 1 = "several days a week", 2 = "once per week", 3 = "2 or 3 days a month", 4 = "once a month", 5 = "never"). Scores are summed and range from 0 to 45. Higher scores indicate better symptom management.
Baseline SM-EOLD
Group
Value
95% CI
Standard Care
4
Palliative Care Consult
3
Follow-up SM-EOLD
Group
Value
95% CI
Standard Care
3
Palliative Care Consult
3
Sponsor's own description
Alzheimer's disease and related dementias (ADRD) are serious, life limiting illnesses with no known cure. Dementia is the fifth-leading cause of death in older adults and the majority of people with advanced dementia die in nursing homes (NHs). Miller et al reported that 40% of U.S. NH residents dying with advanced dementia received Skilled Nursing Facility (SNF) care in the last 90 days of life, and receipt of this care was associated significantly with poorer end-of-life outcomes, including a higher risk of dying in a hospital, compared to decedents with no SNF care. SNF care is a Medicare post-acute rehabilitation service delivered in NHs focused on intense rehabilitation and/or aggressive, disease-modifying therapies. Regardless of life expectancy, use of SNF care precludes access to Hospice services. Palliative care (PC) offers an evidence-based alternative.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06545344 — Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm
· NA
· withdrawn
NCT05147935 — Adding Specialist Palliative Care to Transplantation Pilot Trial
· NA
· suspended
NCT05001620 — Implementation of a Telehealth Palliative Care Model for Persons With Dementia
· NA
· completed
NCT03958552 — Palliative Care Consultations in the Skilled Nursing Facility (SNF) Setting
· NA
· completed
NCT03456323 — Post-ICU Palliative Care Intervention (PIPCI) Trial
· NA
· completed
Other recruiting trials for Advance Care Planning
Currently open trials in the same condition.
NCT07235839 — The Impact of an Advance Care Planning Game on Life-Sustaining Treatment Preferences, Depression, and Hope in Older Adul
· NA
· active not recruiting
NCT07134881 — Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE)
· NA
· recruiting
NCT06538493 — Jumpstarting Advance Care Planning With ANAI People
· NA
· recruiting
NCT06731361 — Improved Prescribing for Older Nursing Home Patients
· NA
· recruiting
NCT06376799 — Which Health-care Professional(s) to Talk About Advance Care Planning ?
· recruiting
Other University of Maryland, Baltimore trials
Trials by the same sponsor.
NCT07537413 — Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia
· Phase 4
· not yet recruiting
NCT07221799 — OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
· Phase 1
· not yet recruiting
NCT07094672 — Development of an Opioid Withdrawal Clinical Outcome Assessment
· not yet recruiting
NCT06583239 — Hub-Based Engagement Navigator Service to Reduce CSC Disengagement
· NA
· not yet recruiting
NCT07536412 — Decision Aid Efficacy in Low Risk Thyroid Cancer
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Maryland, Baltimore
Last refreshed: 27 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05308004.